Literature DB >> 10813805

Inhibitory neurophysiological deficit as a phenotype for genetic investigation of schizophrenia.

R Freedman1, C E Adams, L E Adler, P C Bickford, J Gault, J G Harris, H T Nagamoto, A Olincy, R G Ross, K E Stevens, M Waldo, S Leonard.   

Abstract

Many investigators have proposed that biological endophenotypes might facilitate the genetic analysis of schizophrenia. A deficit in the inhibition of the P50 evoked response to repeated auditory stimuli has been characterized as a neurobiological deficit in schizophrenia. This deficit is linked to a candidate gene locus, the locus of the alpha7-nicotinic cholinergic receptor subunit gene on chromosome 15q14. Supportive evidence has been found by other investigators, including: 1) linkage of schizophrenia to the same locus; 2) linkage of bipolar disorder to the locus; and 3) replication of the existence of this neurobiological deficit and its relation to broader neuropsychological deficits in schizophrenia. It is certain that there are many genetic factors in schizophrenia and bipolar disorder; what is needed is a complete and precise description of the contribution of each individual factor to the pathophysiology of these illnesses. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10813805     DOI: 10.1002/(sici)1096-8628(200021)97:1<58::aid-ajmg8>3.0.co;2-y

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  21 in total

1.  Prenatal stress differentially alters brain-derived neurotrophic factor expression and signaling across rat strains.

Authors:  E W Neeley; R Berger; J I Koenig; S Leonard
Journal:  Neuroscience       Date:  2011-04-07       Impact factor: 3.590

Review 2.  Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.

Authors:  William S Stone; Larry J Seidman
Journal:  Schizophr Bull       Date:  2007-05-15       Impact factor: 9.306

3.  Maximizing the effect of an α7 nicotinic receptor PAM in a mouse model of schizophrenia-like sensory inhibition deficits.

Authors:  Karen E Stevens; Lijun Zheng; Kirsten L Floyd; Jerry A Stitzel
Journal:  Brain Res       Date:  2015-03-02       Impact factor: 3.252

4.  Attentional modulation of the P50 suppression deficit in recent-onset and chronic schizophrenia.

Authors:  Cindy M Yee; Terrance J Williams; Patricia M White; Keith H Nuechterlein; Donna Ames; Kenneth L Subotnik
Journal:  J Abnorm Psychol       Date:  2010-02

5.  Inter- and intra-individual covariations of hemodynamic and oscillatory gamma responses in the human cortex.

Authors:  Tino Zaehle; Ingo Fründ; Jeanette Schadow; Stefanie Thärig; Mircea A Schoenfeld; Christoph S Herrmann
Journal:  Front Hum Neurosci       Date:  2009-06-18       Impact factor: 3.169

Review 6.  The endophenotype concept in psychiatric genetics.

Authors:  Jonathan Flint; Marcus R Munafò
Journal:  Psychol Med       Date:  2006-09-18       Impact factor: 7.723

7.  In vitro and in vivo characterisation of Lu AF64280, a novel, brain penetrant phosphodiesterase (PDE) 2A inhibitor: potential relevance to cognitive deficits in schizophrenia.

Authors:  John P Redrobe; Morten Jørgensen; Claus T Christoffersen; Liliana P Montezinho; Jesper F Bastlund; Martin Carnerup; Christoffer Bundgaard; Linda Lerdrup; Niels Plath
Journal:  Psychopharmacology (Berl)       Date:  2014-03-01       Impact factor: 4.530

Review 8.  Research review: Cholinergic mechanisms, early brain development, and risk for schizophrenia.

Authors:  Randal G Ross; Karen E Stevens; William R Proctor; Sherry Leonard; Michael A Kisley; Sharon K Hunter; Robert Freedman; Catherine E Adams
Journal:  J Child Psychol Psychiatry       Date:  2009-11-18       Impact factor: 8.982

9.  Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes.

Authors:  Monica E Calkins; William G Iacono; Deniz S Ones
Journal:  Brain Cogn       Date:  2008-10-18       Impact factor: 2.310

Review 10.  nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.

Authors:  Vinay Parikh; Munir Gunes Kutlu; Thomas J Gould
Journal:  Schizophr Res       Date:  2016-01-21       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.